BGB-B3227-101
Terminated
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Study ID
BGB-B3227-101
ClinicalTrials.gov ID
EudraCT or EUCT Number
2024-514216-27-00
China Drug Trials ID
CTR20244018
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents